Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Reitsma

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Journal of Vascular Research|December 29, 2006
Two-photon microscopy of vital murine elastic and muscular arteries. Combined structural and functional imaging with subcellular resolutionR T A Megens, S Reitsma, P H M Schiffers, et al.
Allergy|November 12, 2025
"Super-Responders" to Dupilumab Treatment in Patients With Primary Diffuse Chronic Rhinosinusitis With Nasal PolypsP E Vonk, J J Otten, H B E Elzinga, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
Complementary roles of platelets and coagulation in thrombus formation on plaques acutely ruptured by targeted ultrasound treatment: a novel intravital modelM J E Kuijpers, K Gilio, S Reitsma, et al.
Rhinology|November 24, 2023
Hypereosinophilia during dupilumab treatment in patients with chronic rhinosinusitis with nasal polypsP Kemp, R J L van der Lans, J J Otten, et al.
Rhinology|March 27, 2026
Revision endoscopic sinus surgery is rarely needed in dupilumab-treated chronic rhinosinusitis with nasal polypsP Kemp, J J Otten, H B E Elzinga, et al.
Rhinology|March 31, 2023
EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023W J Fokkens, A-S Viskens, V Backer, et al.
Frontiers in Allergy|May 30, 2024
Pre-asthma: a useful concept? A EUFOREA paper. Part 2-late onset eosinophilic asthmaG K Scadding, C Gray, D M Conti, et al.
Frontiers in Allergy|February 14, 2024
Pre-asthma: a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1-allergic asthmaG K Scadding, M McDonald, V Backer, et al.
Allergy|April 25, 2026
The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Utricaria, and Chronic Rhinosinusitis With Nasal PolypsL Klimek, J Mullol, S Reitsma, et al.
Rhinology|January 13, 2024
EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNPW J Fokkens, E De Corso, V Backer, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Journal of Vascular Research|December 29, 2006
Two-photon microscopy of vital murine elastic and muscular arteries. Combined structural and functional imaging with subcellular resolutionR T A Megens, S Reitsma, P H M Schiffers, et al.
Allergy|November 12, 2025
"Super-Responders" to Dupilumab Treatment in Patients With Primary Diffuse Chronic Rhinosinusitis With Nasal PolypsP E Vonk, J J Otten, H B E Elzinga, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
Complementary roles of platelets and coagulation in thrombus formation on plaques acutely ruptured by targeted ultrasound treatment: a novel intravital modelM J E Kuijpers, K Gilio, S Reitsma, et al.
Rhinology|November 24, 2023
Hypereosinophilia during dupilumab treatment in patients with chronic rhinosinusitis with nasal polypsP Kemp, R J L van der Lans, J J Otten, et al.
Rhinology|March 27, 2026
Revision endoscopic sinus surgery is rarely needed in dupilumab-treated chronic rhinosinusitis with nasal polypsP Kemp, J J Otten, H B E Elzinga, et al.
Rhinology|March 31, 2023
EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023W J Fokkens, A-S Viskens, V Backer, et al.
Frontiers in Allergy|May 30, 2024
Pre-asthma: a useful concept? A EUFOREA paper. Part 2-late onset eosinophilic asthmaG K Scadding, C Gray, D M Conti, et al.
Frontiers in Allergy|February 14, 2024
Pre-asthma: a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1-allergic asthmaG K Scadding, M McDonald, V Backer, et al.
Allergy|April 25, 2026
The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Utricaria, and Chronic Rhinosinusitis With Nasal PolypsL Klimek, J Mullol, S Reitsma, et al.
Rhinology|January 13, 2024
EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNPW J Fokkens, E De Corso, V Backer, et al.
Pageof 6